General Hematology - Hematology Advisor

General Hematology

GENERAL HEMATOLOGY

FEATURE


LATEST NEWS


Pacritinib More Effective at Spleen Volume Reduction Than Best Available Therapy in Myelofibrosis

Treatment with the multityrosine kinase inhibitor pacritinib resulted in a significant reduction in spleen volume compared with best available therapy, including ruxolitinib, in patients with myelofibrosis and thrombocytopenia, according to a study presented at the American Society of Hematology (ASH) 58th Annual Meeting & Exposition. For the phase 3 PERSIST-2 study (ClinicalTrials.gov identifier: NCT02055781), investigators…
Next post in General Hematology